Folgen
Colinge
Colinge
IRCM, Université de Montpellier, ICM
Bestätigte E-Mail-Adresse bei inserm.fr
Titel
Zitiert von
Zitiert von
Jahr
The CRAPome: a contaminant repository for affinity purification–mass spectrometry data
D Mellacheruvu, Z Wright, AL Couzens, JP Lambert, NA St-Denis, T Li, ...
Nature methods 10 (8), 730-736, 2013
17962013
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome
T Bürckstümmer, C Baumann, S Blüml, E Dixit, G Dürnberger, H Jahn, ...
Nature immunology 10 (3), 266-272, 2009
12782009
Gene essentiality and synthetic lethality in haploid human cells
VA Blomen, P Májek, LT Jae, JW Bigenzahn, J Nieuwenhuis, J Staring, ...
Science 350 (6264), 1092-1096, 2015
9162015
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets
U Rix, O Hantschel, G Dürnberger, LL Remsing Rix, M Planyavsky, ...
Blood, The Journal of the American Society of Hematology 110 (12), 4055-4063, 2007
7812007
IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA
A Pichlmair, C Lassnig, CA Eberle, MW Górna, CL Baumann, TR Burkard, ...
Nature immunology 12 (7), 624-630, 2011
6022011
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
KVM Huber, E Salah, B Radic, M Gridling, JM Elkins, A Stukalov, ...
Nature 508 (7495), 222-227, 2014
4522014
OLAV: Towards high‐throughput tandem mass spectrometry data identification
J Colinge, A Masselot, M Giron, T Dessingy, J Magnin
PROTEOMICS: International Edition 3 (8), 1454-1463, 2003
4132003
Artemisinins target GABAA receptor signaling and impair α cell identity
J Li, T Casteels, T Frogne, C Ingvorsen, C Honore, M Courtney, ...
Cell 168 (1), 86-100. e15, 2017
4012017
Cell-cycle regulation accounts for variability in Ki-67 expression levels
M Sobecki, K Mrouj, J Colinge, F Gerbe, P Jay, L Krasinska, V Dulic, ...
Cancer research 77 (10), 2722-2734, 2017
3772017
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
O Hantschel, U Rix, U Schmidt, T Bürckstümmer, M Kneidinger, G Schütze, ...
Proceedings of the National Academy of Sciences 104 (33), 13283-13288, 2007
3532007
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells
LL Remsing Rix, U Rix, J Colinge, O Hantschel, KL Bennett, T Stranzl, ...
Leukemia 23 (3), 477-485, 2009
3292009
SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics
S Cabello-Aguilar, M Alame, F Kon-Sun-Tack, C Fau, M Lacroix, ...
Nucleic acids research 48 (10), e55-e55, 2020
3272020
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
J Li, U Rix, B Fang, Y Bai, A Edwards, J Colinge, KL Bennett, J Gao, ...
Nature chemical biology 6 (4), 291-299, 2010
3232010
Viral immune modulators perturb the human molecular network by common and unique strategies
A Pichlmair, K Kandasamy, G Alvisi, O Mulhern, R Sacco, M Habjan, ...
Nature 487 (7408), 486-490, 2012
2852012
CD14 is a coreceptor of Toll-like receptors 7 and 9
CL Baumann, IM Aspalter, O Sharif, A Pichlmair, S Blüml, F Grebien, ...
Journal of Experimental Medicine 207 (12), 2689-2701, 2010
2792010
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS
M Varjosalo, R Sacco, A Stukalov, A Van Drogen, M Planyavsky, S Hauri, ...
Nature methods 10 (4), 307-314, 2013
2312013
Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling
KVM Huber, KM Olek, AC Müller, CSH Tan, KL Bennett, J Colinge, ...
Nature methods 12 (11), 1055-1057, 2015
2252015
Charting the molecular network of the drug target Bcr-Abl
M Brehme, O Hantschel, J Colinge, I Kaupe, M Planyavsky, T Köcher, ...
Proceedings of the National Academy of Sciences 106 (18), 7414-7419, 2009
2202009
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer
MK Muellner, IZ Uras, BV Gapp, C Kerzendorfer, M Smida, ...
Nature chemical biology 7 (11), 787-793, 2011
1992011
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
A Fauster, M Rebsamen, KVM Huber, JW Bigenzahn, A Stukalov, ...
Cell death & disease 6 (5), e1767-e1767, 2015
1962015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20